Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin vs Pregabalin for Anxiolysis and Sedation in Hip Arthroplasty
NCT05221151Phase 4Completed
- Sponsor
- Menoufia University
- Start
- Jan 2022
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of melatonin and pregabalin in anxiety disorder, sponsored by Menoufia University. Primary endpoint: Visual Analog Scale at 48 hours. Started Jan 2022; status: completed.
02
Drugs
melatoninpregabalin
03
Conditions
anxiety disorder
Beyond the preview
Go deeper on NCT05221151.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05221151.